The aim of the regulation proposed by the Commission is to enable manufacturers of generic pharmaceutical products to produce and sell patented pharmaceutical products intended for export to countries in need of such products which either have no manufacturing capacity, or are not self-sufficient, in the relevant sector.
The aim of the regulation proposed by the Commission is to enable manufacturers of generic pharmaceutical products to produce and sell patented pharmaceutical products intended for export to countries in need of such products which either have no manufacturing capacity, or are not self-sufficient, in the relevant sector.